Study identifier:NIS-NES-DUM-2007/3
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Effect of daily SMS reminders on medication adherence to oral antipsychotics in patients with schizophrenia
schizophrenia
-
No
-
All
339
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Mar 2010 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
This study is a 6-month, multicenter, randomized study to assess the effect of daily SMS reminders sent during 3 months in the adherence to oral antipsychotic treatment in stabilized outpatients with schizophrenia.
Location
Location
Oviedo, Oviedo, Spain
Location
Santander, Cantabria, Spain
Location
Burgos, Burgos, Spain
Location
Valladolid, Valladolid, Spain
Location
Zamora, Zamora, Spain
Location
Salamanca, Salamanca, Spain
Location
Leon, Leon, Spain
Location
Madrid, Madrid, Spain
Arms | Assigned Interventions |
---|
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.